Sunday, October 26, 2025 7:43:19 AM
Shorts added 1.5M shares. 32% now… Can someone make it make sense?
Shorts added 1.5M shares. 32% now… Can someone make it make sense?
https://fintel.io/ss/us/avxl
AVXL - Anavex Life Sciences Corp. Stock - Share Price, Short Interest, Short Squeeze, Borrow Rates (NasdaqGS)
fintel.io
AVXL - Anavex Life Sciences Corp. Stock - Share Price, Short Interest, Short Squeeze, Borrow Rates (NasdaqGS)Basic Stats
Short Interest 26,617,983 shares - source: NASDAQ
Short Interest Ratio 33.05 Days to Cover
Short Interest % Float 32.07 % - source: NASDAQ (short interest), Capital IQ (float)
Off-Exchange Short Volume 239,861 shares - source: FINRA (inc. Dark Pool volume)
Off-Exchange Short Volume Ratio 72.36 % - source: FINRA (inc. Dark Pool volume)
Introduction
This short interest tracker provides a variety of short interest related data, sourced from a variety of partners. The data is organized by frequency of updates, with intraday data at the top (short shares availability, short borrow fee rate), daily data (short volume, fails-to-deliver) in the middle, and the slowest updated data (short interest) at the bottom. Note that short interest is published twice-monthly, on a schedule set by FINRA.
Read More
Is this card helpful?
Short Squeeze Score
The Short Squeeze Score is the result of a sophisticated, multi-factor quantitative model that identifies companies that have the highest risk of experiencing a short squeeze. The scoring model uses a combination of short interest, float, short borrow fee rates, and other metrics. The number ranges from 0 to 100, with higher numbers indicating a higher risk of a short squeeze relative to its peers, and 50 being the average.
Update Frequency: Intraday
See our Short Squeeze Leaderboards for US, Canada, Australia and Hong Kong
Subscription Required
Is this card helpful?
Short Shares Availability
This table shows the number of shares of US:AVXL available to be shorted at a leading prime brokerage. It is not the total number of shares available to short, nor is it the short interest.
It does not include data from other brokers or dark pools. It is a small sample, and it is useful for tracking the rise and fall in demand for shares throughout the day and weeks. It should not be treated as an absolute number of shares that are available to short in the market.
We update our database every 30 minutes but only display changes, in order to improve readability.
Update Frequency: Intraday
Last update : 12 minutes ago
Time Since
Last Change Timestamp (UTC) US:AVXL Short Shares Availability
7 hours ago 2025-10-26 03:37:38.831 350,000
1 day ago 2025-10-25 01:03:33.813 300,000
1 day ago 2025-10-24 17:12:22.958 350,000
1 day ago 2025-10-24 16:10:13.058 400,000
1 day ago 2025-10-24 12:32:35.025 350,000
2 days ago 2025-10-24 07:52:35.438 100,000
2 days ago 2025-10-24 06:19:35.033 85,000
2 days ago 2025-10-24 01:03:53.977 30,000
2 days ago 2025-10-24 00:32:34.962 55,000
2 days ago 2025-10-23 23:26:19.779 50,000
Shorts added 1.5M shares. 32% now… Can someone make it make sense?
https://fintel.io/ss/us/avxl
AVXL - Anavex Life Sciences Corp. Stock - Share Price, Short Interest, Short Squeeze, Borrow Rates (NasdaqGS)
fintel.io
AVXL - Anavex Life Sciences Corp. Stock - Share Price, Short Interest, Short Squeeze, Borrow Rates (NasdaqGS)Basic Stats
Short Interest 26,617,983 shares - source: NASDAQ
Short Interest Ratio 33.05 Days to Cover
Short Interest % Float 32.07 % - source: NASDAQ (short interest), Capital IQ (float)
Off-Exchange Short Volume 239,861 shares - source: FINRA (inc. Dark Pool volume)
Off-Exchange Short Volume Ratio 72.36 % - source: FINRA (inc. Dark Pool volume)
Introduction
This short interest tracker provides a variety of short interest related data, sourced from a variety of partners. The data is organized by frequency of updates, with intraday data at the top (short shares availability, short borrow fee rate), daily data (short volume, fails-to-deliver) in the middle, and the slowest updated data (short interest) at the bottom. Note that short interest is published twice-monthly, on a schedule set by FINRA.
Read More
Is this card helpful?
Short Squeeze Score
The Short Squeeze Score is the result of a sophisticated, multi-factor quantitative model that identifies companies that have the highest risk of experiencing a short squeeze. The scoring model uses a combination of short interest, float, short borrow fee rates, and other metrics. The number ranges from 0 to 100, with higher numbers indicating a higher risk of a short squeeze relative to its peers, and 50 being the average.
Update Frequency: Intraday
See our Short Squeeze Leaderboards for US, Canada, Australia and Hong Kong
Subscription Required
Is this card helpful?
Short Shares Availability
This table shows the number of shares of US:AVXL available to be shorted at a leading prime brokerage. It is not the total number of shares available to short, nor is it the short interest.
It does not include data from other brokers or dark pools. It is a small sample, and it is useful for tracking the rise and fall in demand for shares throughout the day and weeks. It should not be treated as an absolute number of shares that are available to short in the market.
We update our database every 30 minutes but only display changes, in order to improve readability.
Update Frequency: Intraday
Last update : 12 minutes ago
Time Since
Last Change Timestamp (UTC) US:AVXL Short Shares Availability
7 hours ago 2025-10-26 03:37:38.831 350,000
1 day ago 2025-10-25 01:03:33.813 300,000
1 day ago 2025-10-24 17:12:22.958 350,000
1 day ago 2025-10-24 16:10:13.058 400,000
1 day ago 2025-10-24 12:32:35.025 350,000
2 days ago 2025-10-24 07:52:35.438 100,000
2 days ago 2025-10-24 06:19:35.033 85,000
2 days ago 2025-10-24 01:03:53.977 30,000
2 days ago 2025-10-24 00:32:34.962 55,000
2 days ago 2025-10-23 23:26:19.779 50,000
Recent AVXL News
- Form 8-K - Current report • Edgar (US Regulatory) • 05/22/2026 12:15:26 PM
- Anavex Life Sciences Receives Expected Nasdaq Delinquency Notification • GlobeNewswire Inc. • 05/22/2026 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/15/2026 08:15:25 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 05/14/2026 08:15:30 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 05/11/2026 08:30:22 PM
- CEO Transition and Delayed SEC Filing Put Anavex (AVXL) Leadership Changes in Focus • IH Market News • 05/06/2026 02:52:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2026 11:04:59 AM
- Anavex Life Sciences Board of Directors Appoints Former Senior Vice President of Clinical Development Terrie Kellmeyer, PhD, as Interim Chief Executive Officer • GlobeNewswire Inc. • 05/06/2026 11:00:00 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 05/01/2026 11:18:47 PM
- Anavex Life Sciences Highlights New Scientific Findings on Shared Biology Between Autism and Alzheimer’s Disease • GlobeNewswire Inc. • 04/14/2026 11:30:00 AM
- Anavex Life Sciences to Present at the 25th Annual Needham Virtual Healthcare Conference • GlobeNewswire Inc. • 04/07/2026 11:30:00 AM
- Anavex withdraws EU approval filing for Alzheimer’s therapy • IH Market News • 03/30/2026 12:39:26 PM
- Anavex Life Sciences Provides Comprehensive Regulatory Update • GlobeNewswire Inc. • 03/30/2026 11:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/25/2026 08:06:00 PM
- Anavex withdraws EU marketing application for Alzheimer’s therapy blarcamesine • IH Market News • 03/25/2026 02:06:58 PM
- Anavex Life Sciences Provides Update on Regulatory Review in the EU for Blarcamesine to Treat Early Alzheimer’s Disease • GlobeNewswire Inc. • 03/25/2026 11:30:00 AM
- Anavex Life Sciences Presents New Data from its AD-004 Phase IIb/III Trial at AD/PD 2026 Conference Demonstrating Consistent Correlation Between the Treatment Effect of Oral Blarcamesine and Preservation of Brain Volume in Early Alzheimer’s Disease • GlobeNewswire Inc. • 03/23/2026 11:30:00 AM
- New Scientific Findings Highlight Hypothesis of Autophagy Failure as a Precursor of Amyloid Beta and Tau Pathology in Alzheimer’s Disease • GlobeNewswire Inc. • 03/20/2026 11:30:00 AM
- Anavex Life Sciences Presents Significant Treatment Effects of Blarcamesine in New Advanced Alpha-Synuclein Model of Parkinson’s Disease at AD/PD 2026 Conference • GlobeNewswire Inc. • 03/17/2026 11:30:00 AM
- Anavex Life Sciences to Present at the Citizens Life Sciences Conference • GlobeNewswire Inc. • 03/03/2026 12:30:00 PM
- Anavex Life Sciences to Present at the 46th TD Cowen Annual Health Care Conference • GlobeNewswire Inc. • 02/25/2026 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/25/2026 11:07:01 AM
- Anavex Life Sciences Appoints Seasoned Healthcare Leader to Board of Directors • GlobeNewswire Inc. • 02/23/2026 12:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/09/2026 09:40:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/09/2026 12:31:17 PM
